Browse By: Country ι Category ι Publisher ι Tag

Gene Therapy Partnering Terms and Agreements

Pages » 239
Published By » Current Partnering
Price » $1795
In stock
View Report Details
Description

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in gene therapypartnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value   The Gene Therapy Partnering Terms and Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why ... Click here for more details


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Sep 2013
Price: $2795
Companion Diagnostics Partnering Terms and Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe companion diagnostics partnering deals and agreements entered intby the worlds leading healthcare companies.   The report provides a detailed underst
Published Date: Oct 2013
Price: $1795
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provide
Published Date: Sep 2013
Price: $2795
Pre-clinical Stage Partnering Terms & Agreements in Pharma, Biotech & Diagnostics
The Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement. The report provides a detailed under
Published Date: Jun 2010
Price: $2695

 


 

Related News

China’s Huawei to Setup 4G Network in Cambodia
EMAXX, the Cambodian telecommunications company has signed a deal with the Chinese Huawei on Wednesday to build and develop a 4G network in Cambodia. The contract was signed by Ai Minn, the CEO of EMAXX, and the DGM of Huawei Technologies Weng Kefeng. The signing was performed in the presence of the Chinese Embassy’s Cambodian political councilor Li Zhigong and Kan Channmeta, Secretary of State at the Cambodian Ministry of Posts and Telecom. The contract states that Huawei will build
Date: Sep 18

Cost Watchdog of Britain’s Healthcare Sector Approves GSK’s Melanoma Drug under Price-Cut Conditions
Cost control agency of Britain’s healthcare sector, The National Institute for Health and Care Excellence (NICE), has recommended a drug for melanoma marketed by GlaxoSmithKline after the drug maker offered to supply it at a discounted rate to the National Health Service.  The drug, titled Tafinlar, is currently marketed by GSK but it will soon be transferred to Novartis under a trade deal between the tow companies.  Tafinlar is an oral drug that works in a way similar to R
Date: Sep 18

GFT Publishes Big Data for Financial Services Industry
According to the electronic newsletter issued by the California Independent Petroleum Association on Monday, the refinery project poses major economic questions regarding bringing extra crude barrels into the California market. This will affect the local crude prices in the state.  The oil-by-rail project of Alon USA Energy Inc. on Rosedale Highway stirs several questions regarding the local crude prices in the oil industry of California.  Alon is a Dallas-based oil company that
Date: Sep 18

Weakening Rouble Makes GM Cut Production and Cut Jobs in Russia
Opel Group, the European subsidiary of general Motors has planned to cut production and shed nearly 500 jobs in Russia. The decision comes ahead of the weakening Russian rouble and the drop in local demand due to slow economic growth and Western sanctions. Opel stated that it would cut production from two shifts per day to one, at its St. Petersburg plant where it produces Chevrolet Cruze compact and Opel Astra. The company will also offer voluntary severance letters to nearly 500 of the p
Date: Sep 17

Only 44% Americans Think College Education “Very Important”: Poll
A recent annual poll has revealed some shocking statistics regarding Americans’ views on the need for a college education. The poll showed that only 44% of Americans believed that a college education was “very important”, a drastic drop from 75% just four years ago. The 46th annual PDK-Gallup poll also found that most parents of kids in public schools wish that teacher training programs be more selective and that new teachers work under a certified teacher for at least a yea
Date: Sep 17

Fashion Industry Embraces Technology at London Fashion Week
The London Fashion Week cast the spotlight this week not just on the clothes on the runway, but the technology that surrounded the event. In what could be termed as a new digital first for the fashion industry, Burberry teamed up with Twitter to launch the new click-to-buy button to people across the globe. The British luxury fashion house made its nail paint that will be showcased at the LFW available to Twitterati. The social media website is currently trying out the “buy now” feat
Date: Sep 16

Bitcoin Mining Firm Free from Cease Trade
A Saskatchewan based Dominion Bitcoin Mining Company is now free from cease trade and is operating once again.  The cease-trade order against Bitcoin was lifted in May by the Financial and Consumer Affairs Authority (FCAA) with no penalty being issued after it expired last week.  FCAA’s action toward originally issuing the order was because it believed the mining firm had been looking out for various investors in the Saskatchewan region without actually being registered to
Date: Sep 16

Hawaii Earns a “C” in the Blue Planet Foundation’s 2014 Energy Report Card
According to a report published by Blue Planet Foundation, Hawaii received an “average” grade for its clean energy progress. The Blue Planet Foundation’s 2014 Energy Report Card for Hawaii has shown a slight improvement since 2013 which was at “C-minus”. This year the report card has improved to “C”. The report is a 42-page document which gives a broad perspective of Hawaii’s energy transformation. It overlooks key aspects such as transportation
Date: Sep 16

Coke’s Surge to be Reintroduced in the Global Beverages Market
A flavored drink that was discontinued more than a decade ago by Coca Cola, has again been brought back in the beverages market. This citrus flavored drink called Surge is a Mountain Dew knockoff. This drink is only available at Amazon.com. This happens to be Coca Cola’s first ever e-commerce reintroduction. The reintroduction of Surge has been announced at the “Surge Movement” which is a Facebook Fan site.  The members of this fan site are excited about the return of t
Date: Sep 16

Cipla Rises by 10% in Two Days
In a relatively weaker market, Cipla has managed to rally stocks by 3% up to $10.34, a record high for the pharmaceutical company in the National Stock Exchange (NSE). The latest rally brings the stock for Cipla up by nearly 10% within a span of two days. The stocks rose from a previous $9.46 two days ago. The growth added some relief to a CNX Nifty market that was declining by 1%. The stocks started gaining ground after Cipla launched their anti-asthma inhalers in Germany and Sweden. The
Date: Sep 15

Upcoming Reports

Global Radiotherapy Market (Products & Applications) - Global Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018
Radiotherapy is a treatment for cancer which uses beams of high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying. Also called radiation therapy, radiotherapy is emerging as a major technology for killing the cancer disease. The global radiot
Published By: Transparency Market Research
Price: $4795
Cancer Therapeutics And Biotherapeutics Market- Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
Cancer is affecting about more than 10 million people every year globally and this number is expected to increase by 2.4% by the year 2020 and reach to 14 million. Biotherapy is one of the most promising and new approach in treatment of cancer as it enhances the natural tendency of body to defend
Published By: Transparency Market Research
Price: $4795
Occult Blood Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
Occult blood testing is carried out to test for the presence of microscopic or invisible blood cells in the stool. It is a type of colorectal cancer screening test. Occult blood is the sign of a problem in the digestive system, which can be a polyp, growth, or a cancer in the rectum or colon. Once
Published By: Transparency Market Research
Price: $4595
Nanomedical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Factors such as rising prevalence of chronic medical conditions in the fields of neurosciences and cardiology, increasing research and development initiatives in the healthcare sector, and technological advancements in the field of medical sciences are responsible for the growth of this market.
Published By: Transparency Market Research
Price: $4595
Testosterone Replacement Therapy (TRT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
The testosterone replacement therapy is a process of giving testosterone when testes do not produce sufficient amount of testosterone because of injury, damage or absence. The testosterone replacement therapy has gained the momentum in last decade with high penetration in surgery market. The tes
Published By: Transparency Market Research
Price: $4795
Hospital Infection Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours. These conditions are also known as nosocomial infections. The causative agents of nosocomial infections include various types of microorganisms such as bacteria (Gram-posi
Published By: Transparency Market Research
Price: $4795
Uterine Cancer Therapies and Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Uterine cancer is a cancer of uterus and is classified into the following four types, namely uterine sarcomas, endometrial cancer, cervical cancer and gestational trophoblastic disease. These cancers arise from malignancies of connective tissues, endometrium and cervix uteri of the uterus. Uterine
Published By: Transparency Market Research
Price: $4795
Nucleic Acid Aptamers (Diagnostics and Therapeutics) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Nucleic acid aptamers are species of nucleic acid that are engineered in in vitro selection or SELEX i.e. systematic evolution of ligands by exponential enrichment. Aptamers bind different molecular targets such as proteins, nucleic acids, cells, organisms and other molecules and assist in molecul
Published By: Transparency Market Research
Price: $4795
Cardiac Resynchronization Therapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Cardiac resynchronization therapy (CRT) devices are intended to treat heart failure. These devices aid in the proper synchronization of heart beats by sending small undetectable signals to lower chambers of the heart. This in turn enables the heart to pump blood and oxygen more efficiently. This i
Published By: Transparency Market Research
Price: $4795
Rheumatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
With increasing joint and connective tissue problems caused by hectic lifestyles, non-nutritious food habits, and lack of physical workouts, the demand for rheumatology is on an increase on a global scale. Rheumatology is concerned with the therapy of rheumatic diseases and problems involving join
Published By: Transparency Market Research
Price: $4795